Welcome to our dedicated page for Network-1 Technologies news (Ticker: NTIP), a resource for investors and traders seeking the latest updates and insights on Network-1 Technologies stock.
Network-1 Technologies, Inc. (NYSE American: NTIP) specializes in the development, licensing, and protection of intellectual property (IP) rights. The company collaborates with inventors and patent owners to facilitate the development and monetization of patented technologies. Currently, Network-1 owns 102 U.S. patents and 15 international patents, covering various telecommunications, data networking technologies, document stream operating systems, and media content identification technologies.
Network-1's strategy focuses on acquiring and investing in high-quality patents with significant licensing potential. It actively pursues licensing opportunities for its intellectual property assets. Its core patent portfolios include the Cox, M2M/IoT, HFT, Mirror Worlds, and Remote Power patents. Notably, the Remote Power Patent has generated over $188 million in licensing revenue since May 2007, while the Mirror Worlds Patent Portfolio has brought in $47.15 million to date.
Network-1 continues to expand its patent portfolio. The recent issuance of U.S. Patent No. 11,916,893 enhances its M2M/IoT Patent Portfolio, which now includes 37 issued U.S. patents and several pending applications. These patents cover enabling technologies for eSIMs, 5G network authentication, and modern Internet transport layer security solutions.
Financially, Network-1 reported a net revenue of $2.601 million for the year ended December 31, 2023, primarily from litigation settlements related to its Remote Power Patent. Despite a net loss of $1.457 million, the company's robust cash position of $43.394 million and marketable securities of $43.067 million ensure sufficient liquidity for future operations.
In addition to its core business, Network-1 has a significant investment in ILiAD Biotechnologies, LLC, owning approximately 6.8% of the clinical-stage biotechnology firm. ILiAD's BPZE1 vaccine for whooping cough has shown promising results in Phase 2b clinical trials.
Network-1 also implements a Share Repurchase Program and a consistent dividend policy. The company has repurchased over 9.72 million shares since the program's inception and continues to pay semi-annual cash dividends of $0.05 per share.
Network-1 Technologies (NTIP) announced a semi-annual cash dividend of $0.05 per share, payable on September 30, 2021, to stockholders of record as of September 21, 2021. This move reflects the Board's ongoing review of its dividend policy, which may change based on earnings and financial needs. Network-1 focuses on the development and monetization of its intellectual property, owning 87 patents related to telecommunications and data technologies. The company has generated over $170 million in licensing revenue through its Remote Power Patent.
Network-1 Technologies, Inc. (NTIP) reported its financial results for Q2 2021, revealing no revenue for the quarter but total revenue of $18.7 million for the first half, significantly up from $55,000 in Q2 2020. The revenue surge is attributed to a settlement with Cisco over licensing disputes. Despite a net loss of $783,000 for Q2 2021, the company achieved a net income of $8.7 million for the first half, an improvement from a net loss of $1.9 million in the same period last year. Network-1 maintains a strong cash position of $53.8 million.
Network-1 Technologies, Inc. (NYSE American: NTIP) announced the issuance of U.S. Patent No. 11,082,218, enhancing its M2M/IoT Patent Portfolio to thirty issued U.S. patents. This patent focuses on a module for machine-to-machine communication, crucial for embedded SIM card technology in IoT devices.
Acquired in December 2017, the M2M/IoT Patent Portfolio includes six pending U.S. applications and extends its patent terms to 2033-2034. Network-1 aims to continue expanding this portfolio and capitalizing on licensing opportunities.
Network-1 Technologies (NYSE MKT:NTIP) has settled its patent litigation with Hewlett-Packard and Hewlett-Packard Enterprise for $17 million. The lawsuit, filed in the Eastern District of Texas, involved Network-1's Remote Power Patent (U.S. Patent No. 6,218,930), which pertains to Power over Ethernet (PoE) products. HP will receive a fully paid license for the patent, which expired on March 7, 2020. This settlement enhances Network-1's revenue, which has exceeded $170 million from licensing the Remote Power Patent since 2007.
Network-1 Technologies (NTIP) announced the granting of several patents enhancing its M2M/IoT Patent Portfolio. The European Patent Office granted European Patent No. EP3111689 for an embedded universal integrated circuit card supporting two-factor authentication. Additionally, the UK Intellectual Property Office indicated intentions to grant two other applications related to machine-to-machine communications. With 29 US patents and several foreign applications, the portfolio is expected to remain active until 2033-2034.
Network-1 Technologies (NTIP) has announced an extension of its share repurchase program, allowing for the repurchase of up to $5 million in common stock over the next two years. Since the program's inception in 2011, the company has repurchased over 8.6 million shares at an average price of $1.88 per share, costing approximately $16.29 million. The Board believes this move reflects the company's strong cash position and aims to enhance shareholder value without affecting future plans.
Network-1 Technologies announced impressive financial results for the quarter ended March 31, 2021, with revenue of $18.69 million, a significant increase from just $161,000 in the same quarter of 2020. This growth is attributed to a favorable resolution of a contractual dispute with Cisco regarding the Remote Power Patent. The company reported a net income of $9.45 million, compared to a net loss of $1.34 million a year earlier. Network-1 maintains a strong liquidity position with cash and marketable securities of $41.27 million.
A trial against Hewlett-Packard is set for August 2, 2021.
Network-1 Technologies (NTIP) reported a revenue increase of 45% to $4.4 million for 2020, attributed primarily to a $4.15 million litigation settlement. The company had a net loss of $1.7 million, consistent with the previous year's loss. As of year-end, liquidity stood at $44.87 million in cash and securities, adequate to support operations. Recent legal victories include a favorable ruling against Hewlett-Packard and an $18.69 million settlement with Cisco. Additionally, Network-1 made a $6 million investment in ILiAD Biotechnologies and has ongoing patent litigation involving Google and Facebook.
Network-1 Technologies, Inc. (NYSE American: NTIP) announced a semi-annual cash dividend of $0.05 per common share, payable on March 31, 2021 to shareholders of record as of March 16, 2021. The dividend policy is subject to periodic review by the Board of Directors and may change based on the company's earnings and financial needs. Network-1 focuses on developing and monetizing its intellectual property, owning 84 patents in telecommunications and data networking, and has generated over $151 million from its Remote Power Patent through September 2020.
Network-1 Technologies announced a significant legal victory as the U.S. Court of Appeals overturned a previous judgment of non-infringement regarding its Remote Power Patent against Hewlett-Packard. The court's decision mandates a new trial on infringement and validity, potentially obligating licensees, including Cisco, to pay overdue royalties from Q4 2017 to March 7, 2020. The Remote Power Patent has generated over $147 million in licensing revenue since 2007, and the company continues to pursue monetization opportunities across various patent portfolios.
FAQ
What is the current stock price of Network-1 Technologies (NTIP)?
What is the market cap of Network-1 Technologies (NTIP)?
What does Network-1 Technologies, Inc. do?
What are Network-1's core business areas?
What are Network-1's most notable patents?
How much revenue has Network-1's Remote Power Patent generated?
What financial condition is Network-1 in?
Does Network-1 pay dividends?
What is the Share Repurchase Program?
What recent achievements has Network-1 made?
What is Network-1's investment in ILiAD Biotechnologies?